Biogen said the U.S. drug regulator has narrowed the patient group that can use its Alzheimer's disease drug, after the agency drew sharp criticism for approving the drug last month without proof of clear benefit against the disease.

#Biogen #Alzheimer #Aduhelm #FDA #News #Reuters

Subscribe: http://smarturl.it/reuterssubscribe

Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.

Get the latest news on: http://reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en